Get the Stockscreener App
53.44
1.97%
1.1211
Tempus Ai Inc stock is traded at $53.44, with a volume of 1.61M.
It is up +1.97% in the last 24 hours and up +21.44% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$52.32
Open:
$51.94
24h Volume:
1.61M
Relative Volume:
0.27
Market Cap:
$9.62B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-31.10
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
+9.28%
1M Performance:
+21.44%
6M Performance:
-21.67%
1Y Performance:
-25.90%
1-Day Range:
$51.30
$54.23
1-Week Range:
$47.12
$54.23
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
53.57 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
160.80 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.29 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
86.88 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.61 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 39% Potential Upside Amidst Cutting-Edge Healthcare Innovations - DirectorsTalk Interviews
Entropy Technologies LP Purchases New Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (TEM) Stock After 23% Year-To-Date Decline Is Opportunity Emerging - Yahoo Finance
Tangible book value per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Revenue per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Debt to assets ratio of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Kelli Teno-Manalli Joins Tempus AI as Vice President, Head of Communications - hrtoday.in
Tempus AI Stock (TEM) Opinions on Earnings Guidance and Acquisition Speculation - Quiver Quantitative
Tempus AI: AI Precision Medicine With A Moat (NASDAQ:TEM) - Seeking Alpha
Tempus AI (TEM) Achieves Major Milestone with ECG Software Validation - GuruFocus
Tempus AI study validates heart rhythm prediction software - Investing.com
Tempus AI study validates heart rhythm prediction software By Investing.com - Investing.com South Africa
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm - Business Wire
Franklin Resources Inc. Has $109.94 Million Holdings in Tempus AI, Inc. $TEM - MarketBeat
TEM News | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI (TEM) Is One Of The Best Healthcare Mid-Cap AI Stock According To Analysts - Yahoo Finance
Amova Asset Management Americas Inc. Has $206.96 Million Stock Position in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI: The Compression Has Outrun The BusinessUpgrading To Buy (NASDAQ:TEM) - Seeking Alpha
Tempus AI: A Unique AI Business Model With Asymmetric Upside (NASDAQ:TEM) - Seeking Alpha
RNA add-on to DNA tests helps turn uncertain genes into answers - Stock Titan
Alethea Capital Management LLC Makes New Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
TEM: Tempus leverages integrated data and AI to drive diagnostics growth and pharma partnerships - TradingView
Great News: This Explosive Healthcare Stock Could Be a Powerful Artificial Intelligence Winner - The Motley Fool
AI that predicts clinical outcomes? Tempus AI in focus after ASCO data reveal - MSN
Norges Bank Purchases New Position in Tempus AI, Inc. $TEM - MarketBeat
Contrarius Group Holdings Ltd Makes New Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - BioSpace
Tempus AI, Inc. Class A Trade Ideas — XETR:F3M - TradingView
Tempus AI to present at Goldman Sachs healthcare conference - scanx.trade
A Quick Look at Today's Ratings for Tempus AI(TEM.US), With a Forecast Between $60 to $80 - Moomoo
Geode Capital Management LLC Boosts Holdings in Tempus AI, Inc. $TEM - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Assessing Tempus AI (TEM) Valuation After Recent Share Price Rebound And Underpriced Growth Narrative - Yahoo Finance
TD Cowen raises Tempus AI stock price target on genomics strength - Investing.com
ARK's Stock Pick: $LLY & $TEM Hold Strong as AI Growth Stocks Plunge — Defensive Biotech Shines - Moomoo
$Tempus AI (TEM.US)$ Luckily, I exited yesterday[Lol] - Moomoo
TEM Technical Analysis & Stock Price Forecast - Intellectia AI
Tempus (TEM) Gets Double-Digit Boost from New Partnerships - Insider Monkey
Tempus AI (NASDAQ:TEM) Trading Up 9.3%Time to Buy? - MarketBeat
Tempus AI Stock Pops As FDA Win Fuels Growth Story - StocksToTrade
Why Tempus AI Stock Is Surging On Thursday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus AI falls on wider loss despite revenue beat By Investing.com - Investing.com Australia
Tempus AI (TEM) Jumps As FDA Win Fuels Bullish Momentum - timothysykes.com
Why Is Tempus (TEM) Down 11.2% Since Last Earnings Report? - Yahoo Finance
$Tempus AI (TEM.US)$ thanks for the ride [Drool] - Moomoo
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members - BioSpace
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):